RJ Hamster
🌎 James Hardie Industries Upgraded, Norwegian Cruise Line Downgraded,…
| Ratings changes for Upstart, Zillow Group, Freshworks, Lyft, Robinhood Markets, Cleanspark, Lyft and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.Unsubscribe.VIEW MY PORTFOLIOFEBRUARY 11TH, 2026Is Trump Done? Shocking leak… (ad)Ian King has learned from a White House leak that President Trump is expected to sign what may be his final executive order on February 24th. After issuing 220 executive orders in one year with nearly three full years left in office, this announcement appears significant. King, chief strategist at Strategic Fortunes, reviewed the leaked details and believes this could be a major development. He’s prepared a full briefing on what this executive order could mean and why it may be Trump’s last. GET THE FULL STORY HEREToday’s Top StoriesAI Disruption Overblown! 4 Software Stocks to Buy on the DipBY THOMAS HUGHES | FEBRUARY 11, 2026 08:33 AMThe Calm Before the Rotation — What’s Quietly Building Now (Ad)BY STOCK WIRE NEWSOnsemi Is Near a Breakout—And Free Cash Flow Could Fuel ItBY THOMAS HUGHES | FEBRUARY 11, 2026 07:19 AMWhat to Make of D-Wave’s Latest Defense Industry PushBY NATHAN REIFF | FEBRUARY 10, 2026 04:47 PMMomentum Trackers Just Lit Up — Here’s Why (Ad)BY STOCK NEWS TRENDSRocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?BY RYAN HASSON | FEBRUARY 10, 2026 03:23 PMAhead of Q4 Earnings, CoreWeave Is Up 142% Over the Past YearBY JORDAN CHUSSLER | FEBRUARY 10, 2026 10:19 AMQuick LinksAnalyst RatingsMy MarketBeatAccount SettingsMarketBeat All AccessStock ListsStock ScreenerCalculatorsPremium ReportsBest Stocks to Buy in February[URGENT] Independent analyst just valued this Nasdaq biotech’s lead drug at $1 BILLION (ad)Vyome Holdings, Inc’s. (Nasdaq: HIND) Lead Drug Valued at $1 Billion…And They’ve Just Locked in Phase 3 Funding Last week, Vyome Holdings, Inc. (Nasdaq: HIND) dropped two pieces of significant news that have this small-cap biotech looking seriously undervalued. WITH PHASE 3 FULLY CAPITALIZED AND MULTIPLE CATALYSTS ON THE HORIZON, THIS IS A NAME TO WATCH CLOSELYour WatchlistMANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO Apple Inc. (AAPL) $276.14 +2.46 (+0.90%) As of 2/11/2026 9:42 AM ETApple Inc. (NASDAQ:AAPL) declared a quarterly dividend on Thursday, January 29th. Investors of record on Monday, February 9th will be given a dividend of 0.26 per share by the iPhone maker on Thursday, February 12th. This represents a c) dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, February 9th. What Really Matters to Grow Your Wealth 2/11 – INVESTORPLACENations Financial Group Inc. IA ADV Has $38.65 Million Stock Holdings in Apple Inc. $AAPL 2/11 – MARKETBEATKuhn & Co Investment Counsel Reduces Stock Position in Apple Inc. $AAPL 2/11 – MARKETBEATApple Stock To Rise Despite Memory Chip Crunch, Says Top Analyst— Hints At ‘Bigger Story’ Unfolding In 2026 2/11 – BENZINGAApple’s FCF Margins Surge and Its Target Value Rises – What’s the Best AAPL Stock Play? 2/11 – YAHOO Amazon.com, Inc. (AMZN) $205.71 -1.25 (-0.60%) As of 2/11/2026 9:42 AM ETAstera Labs in focus as analysts debate results, Amazon deal 2/11 – SEEKINGALPHACircana Appoints Highly Regarded Business Leaders to Board of Directors 2/11 – GLOBENEWSWIREWall Street Breakfast Podcast: Amazon Adds BETA To Cart 2/11 – SEEKINGALPHAAmazon Pharmacy to expand same-day delivery to about 4,500 US cities and towns 2/11 – REUTERSSpear Holdings RSC Ltd Purchases 66,642 Shares of Amazon.com, Inc. $AMZN 2/11 – MARKETBEAT Alphabet Inc. (GOOGL) $317.65 -0.93 (-0.29%) As of 2/11/2026 9:42 AM ETMicrosoft and Google face $650bn AI spending test as sell-off opens fresh entry point 2/11 – PROACTIVEINVESTORSOne Wealth Advisors LLC Purchases 1,770 Shares of Alphabet Inc. $GOOGL 2/11 – MARKETBEATAlphabet Inc. $GOOGL Shares Bought by Phoenix Financial Ltd. 2/11 – MARKETBEAT48% of Billionaire Bill Ackman’s Portfolio Is Invested in 3 AI Stocks, One of Which Is Expected to See Its Addressable Market 10X by 2033 2/11 – FOOLGoogle Cloud Is Turning AI Demand Into Profits. Should You Buy the Stock? 2/10 – FOOL Meta Platforms, Inc. (META) $671.70 +0.98 (+0.15%) As of 2/11/2026 9:42 AM ETStrategy Asset Managers LLC Has $5.24 Million Position in Meta Platforms, Inc. $META 2/11 – MARKETBEATJones Financial Companies Lllp Boosts Stake in Meta Platforms, Inc. $META 2/11 – MARKETBEATFormer Facebook employee testifies against tech company Meta in Santa Fe trial 2/10 – SANTAFENEWMEXICANFisher Asset Management boosts Meta Platforms stake by 113,474 shares 2/10 – TIPRANKSIntermede Investment Partners boosts Meta Platforms stake by 8,909 2/10 – TIPRANKS Microsoft Corporation (MSFT) $409.30 -3.97 (-0.96%) As of 2/11/2026 9:42 AM ETMicrosoft and Google face $650bn AI spending test as sell-off opens fresh entry point 2/11 – PROACTIVEINVESTORSMicrosoft Stock (MSFT) Rises on Sovereign Cloud Collab with French IT Giant 2/11 – TIPRANKSMicrosoft: When Fundamentals And Technicals Align, It’s Time To Buy 2/11 – SEEKINGALPHAMicrosoft Corporation $MSFT Shares Bought by Oak Ridge Investments LLC 2/11 – MARKETBEATTred Avon Family Wealth LLC Makes New $11.78 Million Investment in Microsoft Corporation $MSFT 2/11 – MARKETBEAT MANAGE YOUR WATCHLIST Analysts’ UpgradesClorox (NYSE:CLX) was upgraded by analysts at BNP Paribas Exane from an “underperform” rating to a “neutral” rating.The current price is $123.34.James Hardie Industries (NYSE:JHX) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating.The current price is $26.31.Monro Muffler Brake (NASDAQ:MNRO) was upgraded by analysts at Oppenheimer Holdings, Inc. from a “market perform” rating to an “outperform” rating. They now have a $40.00 price target on the stock. This represents a 75.5% upside from the current price of $22.80.Porch Group (NASDAQ:PRCH) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $10.50 price target on the stock, down previously from $13.00. This represents a 42.1% upside from the current price of $7.39.Radian Group (NYSE:RDN) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $42.00 price target on the stock, up previously from $41.00. This represents a 24.9% upside from the current price of $33.64.Tyler Technologies (NYSE:TYL) was upgraded by analysts at DA Davidson from a “neutral” rating to a “buy” rating. They now have a $460.00 price target on the stock, down previously from $510.00. This represents a 27.9% upside from the current price of $359.56. VIEW MORE UPGRADES The Greatest “Trump Trade” of All Time (ad)The greatest “Trump Trade” of all time has nothing to do with politics. It’s about one material — buried in a small North Carolina town — that controls the future of AI, semiconductors, and every piece of advanced technology on Earth. America holds over 80% of the world’s supply. TO CONTINUE READING, CLICK HERE…Analysts’ DowngradesAtriCure (NASDAQ:ATRC) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $36.00 price target on the stock. This represents a 13.2% upside from the current price of $31.80.BP (NYSE:BP) was downgraded by analysts at Melius Research from a “buy” rating to a “sell” rating. They now have a $31.00 price target on the stock. This represents a 18.8% downside from the current price of $38.18.Harmony Biosciences (NASDAQ:HRMY) was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating. They now have a $46.00 price target on the stock, up previously from $43.00. This represents a 24.2% upside from the current price of $37.03.Installed Building Products (NYSE:IBP) was downgraded by analysts at Benchmark Co. from a “buy” rating to a “hold” rating.The current price is $330.72.Mattel (NASDAQ:MAT) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating. They now have a $14.00 price target on the stock. This represents a 8.2% downside from the current price of $15.26.Norwegian Cruise Line (NYSE:NCLH) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating. They now have a $23.00 price target on the stock. This represents a 1.1% downside from the current price of $23.26.QUALCOMM (NASDAQ:QCOM) was downgraded by analysts at Daiwa Securities Group Inc. from an “outperform” rating to a “neutral” rating. They now have a $140.00 price target on the stock. This represents a 0.1% upside from the current price of $139.84.Millicom International Cellular (NASDAQ:TIGO) was downgraded by analysts at Scotiabank from a “sector perform” rating to a “sector underperform” rating. They now have a $43.00 price target on the stock, down previously from $46.80. This represents a 33.1% downside from the current price of $64.23.Trex (NYSE:TREX) was downgraded by analysts at Benchmark Co. from a “buy” rating to a “hold” rating.The current price is $44.26.Vizsla Silver (NYSEAMERICAN:VZLA) was downgraded by analysts at National Bank Financial from an “outperform” rating to a “sector perform” rating.The current price is $3.94. VIEW MORE DOWNGRADES [URGENT!] SpaceX Going Public! – Pre-IPO Action! (ad)A growing number of investors are paying attention to developments around private space companies and potential future public listings. In a recent briefing, one research publisher outlines how some investors are seeking early exposure to the space economy through publicly traded assets — without waiting for a formal IPO. The presentation walks through the structure, risks, and mechanics behind this approach for those who want to understand how it works. READ THE FULL SPONSOR BRIEFING HEREAnalysts’ New CoverageOlema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $48.00 price target on the stock. This represents a 109.4% upside from the current price of $22.93.Prenetics Global (NASDAQ:PRE) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $36.00 price target on the stock. This represents a 60.6% upside from the current price of $22.42. VIEW MORE NEW COVERAGE Calendars from MarketBeatU.S. Analyst RatingsCongressional BuyingCorporate BuybacksCryptocurrenciesDividend DeclarationsEarnings AnnouncementsEarnings Conference CallsFDA CalendarGap Up/Down StocksInsider TradesInitial Public Offerings (IPOs)Most Active StocksPercentage Gainers/DeclinersSector PerformanceShort InterestStock SplitsUnusual Options VolumeUnusual Trading VolumeGET 30 DAYS OF MARKETBEAT ALL ACCESS FREESign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL  Thank you for subscribing to MarketBeat!MarketBeat empowers investors to make better financial decisions by delivering up-to-the-minute financial information and best-in-class investment research.If you need help with your account, feel free to email our South Dakota based support team at contact@marketbeat.com. If you wish to unsubscribe or modify which newsletters you subscribe to, you can manage your mailing preferences or unsubscribe from this newsletter. © 2006-2026 MarketBeat Media, LLC. All rights protected. 345 N Reid Pl., Sixth Floor, Sioux Falls, South Dakota 57103. U.S.A..Just For You: Trump’s Final Shocking Act Begins February 24 (From Banyan Hill Publishing) |
